Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
1.210
-0.060 (-4.72%)
At close: Jun 5, 2026, 4:00 PM EDT
1.220
+0.010 (0.83%)
After-hours: Jun 5, 2026, 7:36 PM EDT
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $41.6 million as of June 5, 2026. Its market cap has decreased by -34.38% in one year.
Market Cap
41.60M
Enterprise Value
36.24M
1-Year Change
-34.38%
Ranking
Category
Stock Price
$1.21
Market Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $41.60M, a decrease of -79.93%. That is a compound annual growth rate of -49.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 41.60M | -9.02% |
| Dec 31, 2025 | 45.73M | -62.70% |
| Dec 31, 2024 | 122.58M | -40.86% |
| Feb 9, 2024 | 207.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xilio Therapeutics | 46.79M |
| aTyr Pharma | 46.60M |
| Lantern Pharma | 46.39M |
| Tevogen Bio Holdings | 45.69M |
| Actuate Therapeutics | 45.46M |
| Hyperion DeFi | 43.04M |
| Nutriband | 42.55M |
| RenovoRx | 41.02M |